What does a ferritin level of 400 ng/mL indicate and how should it be evaluated and managed?

Evaluation and Management of Ferritin 400 ng/mL

A ferritin level of 400 ng/mL requires immediate assessment of transferrin saturation (TSAT) to distinguish true iron overload from inflammatory elevation, followed by HFE genetic testing if TSAT ≥45%, because this combination strongly suggests hereditary hemochromatosis requiring therapeutic phlebotomy. 1

Initial Diagnostic Approach

Measure transferrin saturation immediately as the critical next step, because ferritin alone cannot differentiate iron overload from inflammation—chronic liver disease, hepatitis C, non-alcoholic fatty liver disease, alcoholic liver disease, and malignancy all elevate ferritin without true iron excess. 2, 1

Interpretation Based on TSAT Results

If TSAT ≥45% with ferritin 400 ng/mL:

• Proceed directly to HFE mutation analysis (C282Y and H63D testing), as this combination has high sensitivity for detecting hereditary hemochromatosis. 2, 1
• This ferritin level in a C282Y homozygote indicates moderate iron accumulation but predicts **<2% risk of cirrhosis** (the threshold is ferritin >1000 ng/mL). 1

If TSAT <45% with ferritin 400 ng/mL:

• The elevation likely reflects inflammation or necroinflammatory liver disease rather than iron overload. 2, 1
• Evaluate for underlying conditions: check liver enzymes (AST, ALT), assess for chronic hepatitis B/C, screen for metabolic syndrome, and consider malignancy workup if clinically indicated. 2, 1

Risk Stratification and Further Testing

Ferritin 400 ng/mL falls below the critical 1000 ng/mL threshold that predicts cirrhosis risk in hereditary hemochromatosis, so liver biopsy is not indicated at this level if liver enzymes are normal and alcohol consumption is not excessive. 3, 1

When to Pursue Genetic Testing

• Any patient with TSAT ≥45% and/or ferritin above laboratory upper limit should undergo HFE mutation analysis. 1
• Screen first-degree relatives of confirmed hemochromatosis patients regardless of their ferritin level. 1
• C282Y/H63D compound heterozygotes may develop iron overload even with normal TSAT, so genetic testing remains valuable when clinical suspicion is high. 1

Management Decisions

If C282Y Homozygote Confirmed

Initiate therapeutic phlebotomy as the definitive treatment:

• Induction phase: Remove 400–500 mL blood weekly or every 2 weeks, targeting ferritin 50–100 ng/mL (but not below 50 ng/mL to avoid iron deficiency). 3
• Monitor hemoglobin at each session; discontinue if hemoglobin drops below 11 g/dL. 3
• Check ferritin monthly during induction until it decreases below 200 ng/mL, then measure every 1–2 sessions down to target. 3

Maintenance phase:

• Target ferritin 50–100 ng/mL, though more relaxed targets (<200 ng/mL in women, <300 ng/mL in men) are tolerated in elderly patients. 3, 1
• Phlebotomy frequency: every 1–4 months depending on iron accumulation rate. 3
• Monitor ferritin every 6 months to adjust treatment schedule. 3, 1

If Non-HFE Iron Overload Suspected

When ferritin is 400 ng/mL with elevated TSAT but HFE mutations are absent and liver enzymes are elevated, consider liver biopsy for hepatic iron concentration to clarify the diagnosis. 1

Common Pitfalls to Avoid

• Do not interpret elevated ferritin as iron overload without checking TSAT first—this leads to misdiagnosis in inflammatory conditions where ferritin acts as an acute-phase reactant. 1
• Avoid targeting ferritin <20 ng/mL during phlebotomy, as this paradoxically increases dietary non-heme iron absorption and can cause symptomatic iron deficiency. 3, 1
• Do not discontinue hepatocellular carcinoma surveillance in cirrhotic patients even after successful iron depletion, as HCC accounts for approximately 30% of hemochromatosis-related deaths. 1
• Require complete alcohol abstinence in cirrhotic patients undergoing iron depletion therapy. 1

Monitoring Strategy

• During induction: Hemoglobin at every phlebotomy session, ferritin monthly. 3
• During maintenance: Ferritin every 6 months, TSAT as needed to guide phlebotomy frequency. 3, 1
• If ferritin rises to >1000 ng/mL in future: Reassess for cirrhosis risk with liver enzymes, platelet count, and consider imaging or biopsy. 1